

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 7.67688136 |
| 2 | negative regulation of cell killing (GO:0031342) | 7.67688136 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.49664634 |
| 4 | positive thymic T cell selection (GO:0045059) | 6.25869237 |
| 5 | negative T cell selection (GO:0043383) | 5.73894664 |
| 6 | positive T cell selection (GO:0043368) | 5.63772027 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.62324372 |
| 8 | negative thymic T cell selection (GO:0045060) | 5.59606644 |
| 9 | response to interleukin-15 (GO:0070672) | 5.45210613 |
| 10 | interferon-gamma production (GO:0032609) | 5.17029829 |
| 11 | tolerance induction (GO:0002507) | 5.08156774 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 5.08115803 |
| 13 | thymic T cell selection (GO:0045061) | 5.06832500 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.03609236 |
| 15 | cellular response to interleukin-15 (GO:0071350) | 5.00599274 |
| 16 | T cell selection (GO:0045058) | 4.73900831 |
| 17 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.71979534 |
| 18 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.64270783 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.57128447 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.30842663 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.30357259 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.30357259 |
| 23 | positive regulation of granulocyte differentiation (GO:0030854) | 4.29593048 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.28981569 |
| 25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.18057283 |
| 26 | T cell migration (GO:0072678) | 4.10483477 |
| 27 | positive regulation of isotype switching (GO:0045830) | 3.89652441 |
| 28 | leukocyte aggregation (GO:0070486) | 3.87491169 |
| 29 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.81020364 |
| 30 | positive regulation of interleukin-2 production (GO:0032743) | 3.53007664 |
| 31 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.52460502 |
| 32 | T cell receptor signaling pathway (GO:0050852) | 3.52051872 |
| 33 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.47275910 |
| 34 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.47275910 |
| 35 | activated T cell proliferation (GO:0050798) | 3.44078798 |
| 36 | negative regulation of bone resorption (GO:0045779) | 3.43159018 |
| 37 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.42947417 |
| 38 | regulation of B cell differentiation (GO:0045577) | 3.42519037 |
| 39 | positive regulation of DNA recombination (GO:0045911) | 3.42474190 |
| 40 | regulation of T cell tolerance induction (GO:0002664) | 3.41640590 |
| 41 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.41606483 |
| 42 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.36114768 |
| 43 | Peyers patch development (GO:0048541) | 3.36114768 |
| 44 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.36059928 |
| 45 | T cell costimulation (GO:0031295) | 3.35635997 |
| 46 | negative regulation of T cell mediated immunity (GO:0002710) | 3.35443576 |
| 47 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.34894824 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 3.32302339 |
| 49 | detection of bacterium (GO:0016045) | 3.31439686 |
| 50 | lymphocyte costimulation (GO:0031294) | 3.30535921 |
| 51 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.28923590 |
| 52 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.28923590 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.27555056 |
| 54 | detection of other organism (GO:0098543) | 3.22866847 |
| 55 | defense response to protozoan (GO:0042832) | 3.22843723 |
| 56 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.20789960 |
| 57 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.19992187 |
| 58 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.19992187 |
| 59 | regulation of isotype switching (GO:0045191) | 3.19878314 |
| 60 | positive regulation of interleukin-17 production (GO:0032740) | 3.17979575 |
| 61 | * antigen receptor-mediated signaling pathway (GO:0050851) | 3.14998266 |
| 62 | regulation of granulocyte differentiation (GO:0030852) | 3.14755820 |
| 63 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.12883306 |
| 64 | positive regulation by symbiont of host defense response (GO:0052509) | 3.12883306 |
| 65 | regulation of tolerance induction (GO:0002643) | 3.12247274 |
| 66 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.10467596 |
| 67 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.06370300 |
| 68 | response to type I interferon (GO:0034340) | 3.06304923 |
| 69 | cellular response to type I interferon (GO:0071357) | 3.04388567 |
| 70 | type I interferon signaling pathway (GO:0060337) | 3.04388567 |
| 71 | mature B cell differentiation (GO:0002335) | 3.03472474 |
| 72 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.02169007 |
| 73 | positive regulation of humoral immune response (GO:0002922) | 3.00509259 |
| 74 | positive regulation of B cell mediated immunity (GO:0002714) | 3.00406800 |
| 75 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.00406800 |
| 76 | immunoglobulin mediated immune response (GO:0016064) | 2.99533357 |
| 77 | T cell proliferation (GO:0042098) | 2.98951661 |
| 78 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.98041694 |
| 79 | response to protozoan (GO:0001562) | 2.96431784 |
| 80 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.96227315 |
| 81 | negative regulation of adaptive immune response (GO:0002820) | 2.95905953 |
| 82 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.95243261 |
| 83 | lymph node development (GO:0048535) | 2.95169071 |
| 84 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.94974771 |
| 85 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.93816593 |
| 86 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.93749091 |
| 87 | regulation of cell killing (GO:0031341) | 2.93709878 |
| 88 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.93371506 |
| 89 | germinal center formation (GO:0002467) | 2.93043431 |
| 90 | cellular extravasation (GO:0045123) | 2.92300746 |
| 91 | neutrophil activation involved in immune response (GO:0002283) | 2.91673008 |
| 92 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.89997819 |
| 93 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.88419004 |
| 94 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.86263835 |
| 95 | T-helper cell differentiation (GO:0042093) | 2.86263835 |
| 96 | myeloid dendritic cell activation (GO:0001773) | 2.84795588 |
| 97 | regulation of interleukin-2 production (GO:0032663) | 2.81118812 |
| 98 | positive regulation of B cell differentiation (GO:0045579) | 2.81089121 |
| 99 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.80765982 |
| 100 | * B cell receptor signaling pathway (GO:0050853) | 2.77870444 |
| 101 | myeloid dendritic cell differentiation (GO:0043011) | 2.75780037 |
| 102 | regulation of regulatory T cell differentiation (GO:0045589) | 2.75112307 |
| 103 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.73601117 |
| 104 | alpha-beta T cell activation (GO:0046631) | 2.72841912 |
| 105 | positive regulation of tolerance induction (GO:0002645) | 2.71770509 |
| 106 | T cell homeostasis (GO:0043029) | 2.71289725 |
| 107 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.70548082 |
| 108 | natural killer cell activation (GO:0030101) | 2.70165781 |
| 109 | response to muramyl dipeptide (GO:0032495) | 2.69603316 |
| 110 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.69569545 |
| 111 | leukocyte cell-cell adhesion (GO:0007159) | 2.69489807 |
| 112 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68726420 |
| 113 | T cell differentiation (GO:0030217) | 2.68471365 |
| 114 | mast cell activation (GO:0045576) | 2.68438228 |
| 115 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.67342557 |
| 116 | positive regulation of cell killing (GO:0031343) | 2.67337542 |
| 117 | alpha-beta T cell differentiation (GO:0046632) | 2.66766086 |
| 118 | positive regulation of interferon-gamma production (GO:0032729) | 2.66476939 |
| 119 | negative regulation of bone remodeling (GO:0046851) | 2.66204008 |
| 120 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.66072417 |
| 121 | regulation of B cell mediated immunity (GO:0002712) | 2.65053345 |
| 122 | regulation of alpha-beta T cell activation (GO:0046634) | 2.64127256 |
| 123 | lymphocyte homeostasis (GO:0002260) | 2.60887430 |
| 124 | T cell differentiation involved in immune response (GO:0002292) | 2.58067489 |
| 125 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.58067489 |
| 126 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.58067489 |
| 127 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.56600209 |
| 128 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.56229122 |
| 129 | positive regulation of T cell differentiation (GO:0045582) | 2.54263189 |
| 130 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.52719737 |
| 131 | modulation by symbiont of host immune response (GO:0052553) | 2.52719737 |
| 132 | modulation by symbiont of host defense response (GO:0052031) | 2.52719737 |
| 133 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.52719737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.34486071 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.99800010 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.76296879 |
| 4 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.78488618 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.64114804 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.47415695 |
| 7 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.30052284 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.09072348 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.04862602 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.85023125 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.71279454 |
| 12 | * MYC_22102868_ChIP-Seq_BL_Human | 2.71007574 |
| 13 | * MYB_26560356_Chip-Seq_TH2_Human | 2.66475726 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.63017910 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.62762091 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.48078623 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44002001 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.43674452 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.40341540 |
| 20 | * MAF_26560356_Chip-Seq_TH1_Human | 2.31681757 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.28975561 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.27368465 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.26809467 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.23926771 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.23126360 |
| 26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20085745 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14000362 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.13717188 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.12657478 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.06006996 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.96278827 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93633624 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93330006 |
| 34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.89481991 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.85431559 |
| 36 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.82715179 |
| 37 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.82627030 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.81889763 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79668052 |
| 40 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77046545 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76523468 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74923045 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69726570 |
| 44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61725943 |
| 45 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55232118 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48815189 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46518580 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.43671234 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.40799001 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37501132 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.37341039 |
| 52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35421536 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31401813 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28716464 |
| 55 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28453180 |
| 56 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.26333199 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.24244745 |
| 58 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18927932 |
| 59 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18708596 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.18420556 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17989157 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16578534 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13654975 |
| 64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13277500 |
| 65 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09105547 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08979720 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06462709 |
| 68 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05130740 |
| 69 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03925872 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02992268 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00925382 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99190444 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98582490 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98118591 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96875938 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96486254 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96006274 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95996568 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93062537 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93042527 |
| 81 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92778088 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92045865 |
| 83 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.91534149 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88829515 |
| 85 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.87381378 |
| 86 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.86679512 |
| 87 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.86041158 |
| 88 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84788718 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84012173 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83422767 |
| 91 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.82770835 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.81583459 |
| 93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.81542382 |
| 94 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.81342088 |
| 95 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80324825 |
| 96 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.78592628 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76339206 |
| 98 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.75542508 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.75430118 |
| 100 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73988677 |
| 101 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73783581 |
| 102 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.73621245 |
| 103 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73332061 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.73180445 |
| 105 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.72928428 |
| 106 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.72748366 |
| 107 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.72748366 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72199704 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70942670 |
| 110 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.70875851 |
| 111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.69944298 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69774059 |
| 113 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.68909875 |
| 114 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68668928 |
| 115 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.68066696 |
| 116 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65045954 |
| 117 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.64757627 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.64600972 |
| 119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.63958521 |
| 120 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.62922619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003763_abnormal_thymus_physiology | 3.90374482 |
| 2 | MP0005671_abnormal_response_to | 3.80309670 |
| 3 | MP0000685_abnormal_immune_system | 3.45877424 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.16087458 |
| 5 | * MP0001790_abnormal_immune_system | 3.12615246 |
| 6 | * MP0005387_immune_system_phenotype | 3.12615246 |
| 7 | MP0004510_myositis | 3.08230247 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.94924394 |
| 9 | * MP0001800_abnormal_humoral_immune | 2.85434032 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.73689467 |
| 11 | MP0006082_CNS_inflammation | 2.65854248 |
| 12 | MP0001873_stomach_inflammation | 2.62702584 |
| 13 | MP0003866_abnormal_defecation | 2.58185003 |
| 14 | * MP0002723_abnormal_immune_serum | 2.55258144 |
| 15 | MP0003436_decreased_susceptibility_to | 2.46821306 |
| 16 | * MP0002420_abnormal_adaptive_immunity | 2.41856831 |
| 17 | * MP0002452_abnormal_antigen_presenting | 2.39469973 |
| 18 | * MP0001819_abnormal_immune_cell | 2.39341372 |
| 19 | * MP0002405_respiratory_system_inflammati | 2.33775861 |
| 20 | * MP0002398_abnormal_bone_marrow | 2.15615880 |
| 21 | MP0002933_joint_inflammation | 2.12188280 |
| 22 | MP0003045_fibrosis | 2.11118393 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.05636926 |
| 24 | MP0003183_abnormal_peptide_metabolism | 2.04508084 |
| 25 | * MP0000703_abnormal_thymus_morphology | 2.03182868 |
| 26 | MP0008961_abnormal_basal_metabolism | 2.02934482 |
| 27 | MP0005025_abnormal_response_to | 2.01297225 |
| 28 | MP0009785_altered_susceptibility_to | 1.99845917 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.99290657 |
| 30 | MP0000716_abnormal_immune_system | 1.97129166 |
| 31 | MP0002419_abnormal_innate_immunity | 1.94450148 |
| 32 | MP0003303_peritoneal_inflammation | 1.92060085 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.90654149 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.83291744 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.76890363 |
| 36 | * MP0002722_abnormal_immune_system | 1.74607440 |
| 37 | MP0005310_abnormal_salivary_gland | 1.69373058 |
| 38 | * MP0000689_abnormal_spleen_morphology | 1.69145210 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.64790334 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.62979920 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.59867565 |
| 42 | MP0004947_skin_inflammation | 1.59198153 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.57137080 |
| 44 | MP0001853_heart_inflammation | 1.56549162 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.54544819 |
| 46 | * MP0001845_abnormal_inflammatory_respons | 1.52661758 |
| 47 | MP0002006_tumorigenesis | 1.51366974 |
| 48 | MP0002429_abnormal_blood_cell | 1.50728336 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.50098379 |
| 50 | MP0004808_abnormal_hematopoietic_stem | 1.46351892 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.38848099 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.34901170 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.34480020 |
| 54 | * MP0001851_eye_inflammation | 1.25718415 |
| 55 | MP0000015_abnormal_ear_pigmentation | 1.23764971 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.16305877 |
| 57 | MP0005408_hypopigmentation | 1.10894698 |
| 58 | MP0003724_increased_susceptibility_to | 1.09905255 |
| 59 | MP0003448_altered_tumor_morphology | 1.08838384 |
| 60 | MP0009278_abnormal_bone_marrow | 1.08130200 |
| 61 | MP0000858_altered_metastatic_potential | 1.06553693 |
| 62 | MP0008057_abnormal_DNA_replication | 1.05287013 |
| 63 | MP0002693_abnormal_pancreas_physiology | 1.02451024 |
| 64 | MP0002132_abnormal_respiratory_system | 1.02400886 |
| 65 | MP0005451_abnormal_body_composition | 1.01529335 |
| 66 | MP0002254_reproductive_system_inflammat | 0.99289763 |
| 67 | MP0000569_abnormal_digit_pigmentation | 0.99084628 |
| 68 | MP0005409_darkened_coat_color | 0.98285514 |
| 69 | MP0002909_abnormal_adrenal_gland | 0.97074411 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 0.92944542 |
| 71 | MP0005058_abnormal_lysosome_morphology | 0.91389581 |
| 72 | MP0002095_abnormal_skin_pigmentation | 0.89591081 |
| 73 | MP0003795_abnormal_bone_structure | 0.89472009 |
| 74 | MP0005076_abnormal_cell_differentiation | 0.88213177 |
| 75 | MP0005166_decreased_susceptibility_to | 0.86587544 |
| 76 | MP0003828_pulmonary_edema | 0.86391897 |
| 77 | MP0004883_abnormal_blood_vessel | 0.83878120 |
| 78 | MP0009764_decreased_sensitivity_to | 0.83851531 |
| 79 | MP0008469_abnormal_protein_level | 0.83604986 |
| 80 | MP0009763_increased_sensitivity_to | 0.83600745 |
| 81 | MP0005670_abnormal_white_adipose | 0.82151594 |
| 82 | MP0002019_abnormal_tumor_incidence | 0.80650763 |
| 83 | MP0004084_abnormal_cardiac_muscle | 0.76650808 |
| 84 | MP0004381_abnormal_hair_follicle | 0.76268659 |
| 85 | MP0003787_abnormal_imprinting | 0.71252716 |
| 86 | MP0005075_abnormal_melanosome_morpholog | 0.70772094 |
| 87 | MP0001545_abnormal_hematopoietic_system | 0.69029502 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 0.69029502 |
| 89 | MP0001663_abnormal_digestive_system | 0.68841398 |
| 90 | MP0000371_diluted_coat_color | 0.68796252 |
| 91 | MP0000343_altered_response_to | 0.67043685 |
| 92 | MP0002837_dystrophic_cardiac_calcinosis | 0.66844392 |
| 93 | MP0001502_abnormal_circadian_rhythm | 0.66277428 |
| 94 | MP0005390_skeleton_phenotype | 0.65292769 |
| 95 | MP0005646_abnormal_pituitary_gland | 0.65117576 |
| 96 | MP0001348_abnormal_lacrimal_gland | 0.64798672 |
| 97 | MP0008004_abnormal_stomach_pH | 0.63905951 |
| 98 | MP0003279_aneurysm | 0.63593109 |
| 99 | MP0000372_irregular_coat_pigmentation | 0.62327699 |
| 100 | MP0000003_abnormal_adipose_tissue | 0.62197005 |
| 101 | MP0005164_abnormal_response_to | 0.61745905 |
| 102 | MP0005257_abnormal_intraocular_pressure | 0.60937988 |
| 103 | MP0000490_abnormal_crypts_of | 0.60650669 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.59642089 |
| 105 | MP0009840_abnormal_foam_cell | 0.58576576 |
| 106 | MP0008569_lethality_at_weaning | 0.57019045 |
| 107 | MP0008260_abnormal_autophagy | 0.57002930 |
| 108 | MP0002009_preneoplasia | 0.56769465 |
| 109 | MP0009115_abnormal_fat_cell | 0.55148307 |
| 110 | MP0002928_abnormal_bile_duct | 0.53415089 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.53321363 |
| 112 | MP0000609_abnormal_liver_physiology | 0.53126696 |
| 113 | MP0000013_abnormal_adipose_tissue | 0.52554057 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.52119497 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.51370740 |
| 116 | MP0000733_abnormal_muscle_development | 0.50814184 |
| 117 | MP0005171_absent_coat_pigmentation | 0.50545339 |
| 118 | MP0003091_abnormal_cell_migration | 0.49860796 |
| 119 | MP0002822_catalepsy | 0.48598956 |
| 120 | MP0002168_other_aberrant_phenotype | 0.48450421 |
| 121 | MP0004484_altered_response_of | 0.47082689 |
| 122 | MP0000249_abnormal_blood_vessel | 0.46351211 |
| 123 | MP0002277_abnormal_respiratory_mucosa | 0.45613115 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.44675938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 4.92547961 |
| 2 | Abnormality of T cell number (HP:0011839) | 4.64017168 |
| 3 | Myositis (HP:0100614) | 4.43364662 |
| 4 | Recurrent fungal infections (HP:0002841) | 4.15177782 |
| 5 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.93800114 |
| 6 | Recurrent cutaneous fungal infections (HP:0011370) | 3.93800114 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.82438810 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.82097014 |
| 9 | Optic neuritis (HP:0100653) | 3.82097014 |
| 10 | Abnormality of the fingertips (HP:0001211) | 3.77409220 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.77028273 |
| 12 | IgM deficiency (HP:0002850) | 3.53919481 |
| 13 | Abnormality of T cells (HP:0002843) | 3.49351514 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 3.49242829 |
| 15 | Nasal polyposis (HP:0100582) | 3.40071017 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 3.38678785 |
| 17 | Recurrent viral infections (HP:0004429) | 3.36727082 |
| 18 | Orchitis (HP:0100796) | 3.32548178 |
| 19 | Recurrent bronchitis (HP:0002837) | 3.29494120 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.09010029 |
| 21 | Pulmonary infiltrates (HP:0002113) | 3.08550010 |
| 22 | Stomatitis (HP:0010280) | 3.08386681 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.06610146 |
| 24 | Epiphyseal dysplasia (HP:0002656) | 3.02281939 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.00172758 |
| 26 | Severe combined immunodeficiency (HP:0004430) | 3.00119696 |
| 27 | Inflammation of the large intestine (HP:0002037) | 2.98786511 |
| 28 | Persistence of primary teeth (HP:0006335) | 2.95936190 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 2.89365646 |
| 30 | Chronic diarrhea (HP:0002028) | 2.88783504 |
| 31 | Increased IgE level (HP:0003212) | 2.88457264 |
| 32 | Gastrointestinal inflammation (HP:0004386) | 2.83249513 |
| 33 | Chronic otitis media (HP:0000389) | 2.83198934 |
| 34 | Gingival bleeding (HP:0000225) | 2.82673219 |
| 35 | Increased IgM level (HP:0003496) | 2.78312881 |
| 36 | Arterial thrombosis (HP:0004420) | 2.76340798 |
| 37 | Increased density of long bones (HP:0006392) | 2.76079107 |
| 38 | Abnormality of eosinophils (HP:0001879) | 2.74768766 |
| 39 | Papilloma (HP:0012740) | 2.74729124 |
| 40 | Verrucae (HP:0200043) | 2.74729124 |
| 41 | Papilledema (HP:0001085) | 2.68552647 |
| 42 | Thyroiditis (HP:0100646) | 2.68451705 |
| 43 | Cellulitis (HP:0100658) | 2.56830594 |
| 44 | Keratoconjunctivitis (HP:0001096) | 2.54944570 |
| 45 | Pulmonary embolism (HP:0002204) | 2.53939988 |
| 46 | Eosinophilia (HP:0001880) | 2.53808216 |
| 47 | Recurrent bacterial skin infections (HP:0005406) | 2.51148977 |
| 48 | Hemoptysis (HP:0002105) | 2.49172448 |
| 49 | Mediastinal lymphadenopathy (HP:0100721) | 2.47098870 |
| 50 | Meningitis (HP:0001287) | 2.46110458 |
| 51 | Colitis (HP:0002583) | 2.45239753 |
| 52 | IgA deficiency (HP:0002720) | 2.44457248 |
| 53 | Recurrent skin infections (HP:0001581) | 2.43443985 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 2.41987115 |
| 55 | Gastrointestinal stroma tumor (HP:0100723) | 2.41172546 |
| 56 | Combined immunodeficiency (HP:0005387) | 2.40961075 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39114059 |
| 58 | Urticaria (HP:0001025) | 2.37715989 |
| 59 | Leukocytosis (HP:0001974) | 2.35098216 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.31479922 |
| 61 | Vasculitis (HP:0002633) | 2.31461984 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.31043614 |
| 63 | Hypochromic anemia (HP:0001931) | 2.28953779 |
| 64 | Hypergammaglobulinemia (HP:0010702) | 2.26912124 |
| 65 | Pustule (HP:0200039) | 2.24944622 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.24683129 |
| 67 | Lymphoma (HP:0002665) | 2.24069237 |
| 68 | Gangrene (HP:0100758) | 2.22596685 |
| 69 | Abnormality of the endocardium (HP:0004306) | 2.21263746 |
| 70 | Anorexia (HP:0002039) | 2.20930481 |
| 71 | Abnormality of the pleura (HP:0002103) | 2.18979551 |
| 72 | Spondylolisthesis (HP:0003302) | 2.18042785 |
| 73 | Abnormality of the prostate (HP:0008775) | 2.18023916 |
| 74 | B lymphocytopenia (HP:0010976) | 2.17876188 |
| 75 | Abnormality of B cell number (HP:0010975) | 2.17876188 |
| 76 | Acute hepatic failure (HP:0006554) | 2.16270966 |
| 77 | Hypoplastic ischia (HP:0003175) | 2.15669347 |
| 78 | Abnormal platelet volume (HP:0011876) | 2.15498089 |
| 79 | Prolonged bleeding time (HP:0003010) | 2.14592682 |
| 80 | Petechiae (HP:0000967) | 2.14533542 |
| 81 | Cheilitis (HP:0100825) | 2.14372181 |
| 82 | Lymphopenia (HP:0001888) | 2.13494595 |
| 83 | Severe short stature (HP:0003510) | 2.12291872 |
| 84 | Spontaneous hematomas (HP:0007420) | 2.10649868 |
| 85 | Osteomyelitis (HP:0002754) | 2.10077823 |
| 86 | IgG deficiency (HP:0004315) | 2.08084095 |
| 87 | Viral hepatitis (HP:0006562) | 2.06189706 |
| 88 | Skin rash (HP:0000988) | 2.06108390 |
| 89 | Hypoproteinemia (HP:0003075) | 2.04723914 |
| 90 | Obstructive lung disease (HP:0006536) | 2.03519758 |
| 91 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03519758 |
| 92 | Menorrhagia (HP:0000132) | 2.00157725 |
| 93 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.97598122 |
| 94 | Granulocytopenia (HP:0001913) | 1.97007814 |
| 95 | Polyneuropathy (HP:0001271) | 1.96575779 |
| 96 | Glomerulopathy (HP:0100820) | 1.96496576 |
| 97 | Abnormal platelet function (HP:0011869) | 1.95255736 |
| 98 | Impaired platelet aggregation (HP:0003540) | 1.95255736 |
| 99 | Autoimmune hemolytic anemia (HP:0001890) | 1.94683767 |
| 100 | Basal cell carcinoma (HP:0002671) | 1.93101868 |
| 101 | Increased cerebral lipofuscin (HP:0011813) | 1.92275637 |
| 102 | Joint swelling (HP:0001386) | 1.92118952 |
| 103 | Aortic aneurysm (HP:0004942) | 1.91024761 |
| 104 | Chest pain (HP:0100749) | 1.90498012 |
| 105 | Chronic sinusitis (HP:0011109) | 1.89092252 |
| 106 | Agammaglobulinemia (HP:0004432) | 1.88817329 |
| 107 | Arterial tortuosity (HP:0005116) | 1.88734154 |
| 108 | Sepsis (HP:0100806) | 1.88723236 |
| 109 | Subaortic stenosis (HP:0001682) | 1.84742918 |
| 110 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.84742918 |
| 111 | Arthralgia (HP:0002829) | 1.82969854 |
| 112 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.81603178 |
| 113 | Absent frontal sinuses (HP:0002688) | 1.81301541 |
| 114 | Thrombocytosis (HP:0001894) | 1.80460862 |
| 115 | Fatigue (HP:0012378) | 1.80191110 |
| 116 | Metaphyseal cupping (HP:0003021) | 1.80174256 |
| 117 | Encephalitis (HP:0002383) | 1.78792536 |
| 118 | Emphysema (HP:0002097) | 1.77263235 |
| 119 | Abnormality of the ischium (HP:0003174) | 1.75353556 |
| 120 | Keratitis (HP:0000491) | 1.74743688 |
| 121 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.73827436 |
| 122 | Interstitial pulmonary disease (HP:0006530) | 1.73030910 |
| 123 | Asymmetric septal hypertrophy (HP:0001670) | 1.71531367 |
| 124 | Gingivitis (HP:0000230) | 1.71016591 |
| 125 | Frequent falls (HP:0002359) | 1.70437118 |
| 126 | Periodontitis (HP:0000704) | 1.68424114 |
| 127 | Joint stiffness (HP:0001387) | 1.67217707 |
| 128 | Acute myeloid leukemia (HP:0004808) | 1.66779716 |
| 129 | Bronchitis (HP:0012387) | 1.66627286 |
| 130 | Recurrent sinusitis (HP:0011108) | 1.65987133 |
| 131 | Spinal canal stenosis (HP:0003416) | 1.64632135 |
| 132 | Epistaxis (HP:0000421) | 1.63268515 |
| 133 | Mucopolysacchariduria (HP:0008155) | 1.62973698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.80589268 |
| 2 | TXK | 4.57092959 |
| 3 | JAK3 | 2.92477661 |
| 4 | ITK | 2.79560841 |
| 5 | TYK2 | 2.48280988 |
| 6 | TAOK3 | 2.29947145 |
| 7 | PRPF4B | 2.26196821 |
| 8 | JAK1 | 2.20142420 |
| 9 | FGFR4 | 2.09666620 |
| 10 | ZAP70 | 2.06560349 |
| 11 | EPHA3 | 2.03796649 |
| 12 | IRAK3 | 2.01214047 |
| 13 | EEF2K | 1.92617624 |
| 14 | MAP3K14 | 1.82180075 |
| 15 | MAPK15 | 1.79572683 |
| 16 | NLK | 1.74035149 |
| 17 | FGFR3 | 1.73673385 |
| 18 | EPHB1 | 1.72279219 |
| 19 | TBK1 | 1.71674122 |
| 20 | IKBKE | 1.69841820 |
| 21 | TGFBR2 | 1.69827727 |
| 22 | SIK2 | 1.62846610 |
| 23 | LCK | 1.53815689 |
| 24 | SIK3 | 1.53635148 |
| 25 | HCK | 1.52146988 |
| 26 | TEC | 1.51895594 |
| 27 | ERN1 | 1.43881361 |
| 28 | CSK | 1.43543350 |
| 29 | MAP3K10 | 1.36880686 |
| 30 | STK10 | 1.35865491 |
| 31 | BTK | 1.33570178 |
| 32 | SYK | 1.31771244 |
| 33 | MAP3K13 | 1.29710865 |
| 34 | DMPK | 1.29480074 |
| 35 | MAP3K7 | 1.29336863 |
| 36 | KIT | 1.25876788 |
| 37 | TRIB3 | 1.25708881 |
| 38 | MARK3 | 1.24737618 |
| 39 | FES | 1.22856448 |
| 40 | IKBKB | 1.10932289 |
| 41 | BRD4 | 1.10879228 |
| 42 | CAMK1G | 1.09836377 |
| 43 | RIPK4 | 1.06888317 |
| 44 | HIPK2 | 1.06292019 |
| 45 | PRKCH | 1.05601660 |
| 46 | PKN2 | 1.04609422 |
| 47 | TRPM7 | 1.04573220 |
| 48 | CHUK | 1.01418927 |
| 49 | CSF1R | 1.00707465 |
| 50 | CAMK1D | 0.99221382 |
| 51 | IRAK4 | 0.99132277 |
| 52 | MAP2K3 | 0.95853572 |
| 53 | JAK2 | 0.95517306 |
| 54 | TTN | 0.94930049 |
| 55 | PRKCQ | 0.94068633 |
| 56 | GRK6 | 0.93196383 |
| 57 | PIK3CG | 0.92428510 |
| 58 | BLK | 0.91350570 |
| 59 | CDK12 | 0.89551235 |
| 60 | CDK9 | 0.85249050 |
| 61 | CDK4 | 0.82726498 |
| 62 | PDGFRB | 0.80460628 |
| 63 | PTK6 | 0.80280226 |
| 64 | MAPK11 | 0.79466595 |
| 65 | STK24 | 0.76230159 |
| 66 | MAP3K3 | 0.76088775 |
| 67 | TNK2 | 0.74859086 |
| 68 | GRK7 | 0.73820894 |
| 69 | TAOK1 | 0.73009004 |
| 70 | IRAK1 | 0.72672837 |
| 71 | NEK9 | 0.72313869 |
| 72 | SMG1 | 0.69223644 |
| 73 | RET | 0.69084913 |
| 74 | LYN | 0.67307387 |
| 75 | MAPK7 | 0.64003011 |
| 76 | RPS6KA4 | 0.59767935 |
| 77 | FLT3 | 0.59527015 |
| 78 | ADRBK2 | 0.56862529 |
| 79 | PIM1 | 0.56486496 |
| 80 | PDGFRA | 0.54653405 |
| 81 | PRKD2 | 0.54429901 |
| 82 | SGK3 | 0.53879972 |
| 83 | INSRR | 0.53724877 |
| 84 | ALK | 0.53291514 |
| 85 | FGR | 0.52701580 |
| 86 | SGK2 | 0.51122275 |
| 87 | EIF2AK3 | 0.50551949 |
| 88 | SCYL2 | 0.48630098 |
| 89 | MAP3K1 | 0.48075583 |
| 90 | PTK2B | 0.46705990 |
| 91 | PDK1 | 0.46077261 |
| 92 | MELK | 0.45062201 |
| 93 | TSSK6 | 0.43103926 |
| 94 | MAP3K11 | 0.43070609 |
| 95 | CLK1 | 0.42704645 |
| 96 | MAP2K6 | 0.42408761 |
| 97 | LRRK2 | 0.41567642 |
| 98 | TAOK2 | 0.40556117 |
| 99 | MAPK12 | 0.40533512 |
| 100 | CDK6 | 0.40131573 |
| 101 | CAMKK2 | 0.39503966 |
| 102 | MARK2 | 0.39471110 |
| 103 | IGF1R | 0.38967189 |
| 104 | FYN | 0.38875368 |
| 105 | MAPK3 | 0.38405189 |
| 106 | SIK1 | 0.38055752 |
| 107 | PDPK1 | 0.37303540 |
| 108 | PRKG2 | 0.35900203 |
| 109 | PRKAA2 | 0.35827958 |
| 110 | MST4 | 0.35634619 |
| 111 | MAP3K2 | 0.35604409 |
| 112 | KDR | 0.35543837 |
| 113 | NUAK1 | 0.34857137 |
| 114 | CDK3 | 0.33673964 |
| 115 | BMPR2 | 0.33043336 |
| 116 | MAPKAPK2 | 0.32885013 |
| 117 | CDC42BPA | 0.31789883 |
| 118 | CAMKK1 | 0.31739292 |
| 119 | OBSCN | 0.31411590 |
| 120 | PASK | 0.31153812 |
| 121 | GSK3A | 0.31054286 |
| 122 | CAMK4 | 0.30951443 |
| 123 | WNK1 | 0.30883108 |
| 124 | TESK2 | 0.30298198 |
| 125 | RPS6KC1 | 0.28706803 |
| 126 | RPS6KL1 | 0.28706803 |
| 127 | STK4 | 0.28416424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.33598349 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.04950620 |
| 3 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.64861500 |
| 4 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.21673663 |
| 5 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.15359869 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.06795022 |
| 7 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03452525 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.00691435 |
| 9 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.79988246 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.79833913 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79113821 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.72562697 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.65513116 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51072615 |
| 15 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43609317 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42771126 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.40645113 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37336002 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.36347481 |
| 20 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.32401637 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30864485 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.30114426 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.28222597 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26344702 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24453644 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21406106 |
| 27 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20848850 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19958879 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17797297 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14761552 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.11540644 |
| 32 | * Hepatitis B_Homo sapiens_hsa05161 | 1.11398717 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10795382 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08871692 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06648578 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.06164751 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04993961 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.04275768 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.02151943 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02061447 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96077991 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94114169 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93787661 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 0.93101920 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89973866 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89185579 |
| 47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86657250 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.86207352 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85966313 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85065467 |
| 51 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82737785 |
| 52 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.82143880 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.80627474 |
| 54 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80414028 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80035889 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79047176 |
| 57 | Asthma_Homo sapiens_hsa05310 | 0.77956894 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76924299 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74800102 |
| 60 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74004166 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73218369 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73048880 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71508229 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69755656 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.69704787 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.68444465 |
| 67 | Olfactory transduction_Homo sapiens_hsa04740 | 0.67693496 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.66366967 |
| 69 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65828649 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64980374 |
| 71 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64925423 |
| 72 | Insulin secretion_Homo sapiens_hsa04911 | 0.64750863 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64348138 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.63946789 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.63633284 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61939105 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61551611 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61297830 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.60867580 |
| 80 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60512228 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.60036623 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.59715207 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.59570293 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59053916 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.58936223 |
| 86 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58924151 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57506017 |
| 88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57482295 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56222614 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56073220 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.55981544 |
| 92 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55578296 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55508646 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.54241538 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53377068 |
| 96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53314471 |
| 97 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.52836502 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52050687 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51813837 |
| 100 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51736450 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50987107 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50443666 |
| 103 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50392113 |
| 104 | Morphine addiction_Homo sapiens_hsa05032 | 0.49998900 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46095499 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.45228993 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44277834 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43617033 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43349109 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.37314536 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36245260 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33120722 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.32765242 |
| 114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32324541 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32159243 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30225344 |
| 117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29555242 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29457731 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27677947 |
| 120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26908254 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18431697 |

